Tech Company Financing Transactions

Clasp Therapeutics Funding Round

Catalio Capital Management, Novo Holdings and Third Rock Ventures participated in a $150 million venture round for Clasp Therapeutics. The financing round was announced on 3/20/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

1450 Research Blvd. 120
Rockville, MD 20850
USA

Phone

Undisclosed

Website

www.clasptx.com

Email Address

[email protected]

Overview

At Clasp Therapeutics, we are expanding the reach of immuno-oncology with novel precision medicines that enable the immune system to identify and specifically destroy hard-to-treat tumors bearing common driver mutations, regardless of tumor type. This approach enables a highly selective paradigm where every patient has the opportunity to respond to treatment.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Robert Ross

        

Chief Scientific Officer

Andrea van Elsas

        

Chief Technical Officer

James Bingham

        

VP - Bus. Development

Julie DeSander

        

VP - Bus. Development

Shannon Devens

        

VP - Human Resources

Caren Block

        

Browse more venture capital transactions:

Prev: 3/20/2024: CyberSaint venture capital transaction
Next: 3/20/2024: Mermaid Chart venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary